03Mar 2024
Cumulative methotrexate dose is not associated with liver fibrosis in moderate to severe psoriasis patients

Cumulative methotrexate dose is not associated with liver fibrosis in moderate to severe psoriasis patients

A cross-sectional study on psoriasis patients investigated liver fibrosis (LF) prevalence and its association with methotrexate and other risk factors. Of 204 participants, 36% had LF, but methotrexate dosage showed no correlation with LF severity. Risk factors for higher LF included high BMI, waist circumference, metabolic syndrome, and alcohol use. Notably, BMI ≥28, diabetes, and metabolic syndrome were better predictors of LF compared to Fib-4 score. These findings underscore the importance of assessing liver health in psoriasis patients, particularly those with specific risk factors like high BMI and metabolic disorders.

  • #dermatology

Like

Save

Share